These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 19531109)
1. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder. Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109 [TBL] [Abstract][Full Text] [Related]
2. Hippocampal 1H MRS in first-episode bipolar I patients. Atmaca M; Yildirim H; Ozdemir H; Poyraz AK; Tezcan E; Ogur E Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1235-9. PubMed ID: 16725248 [TBL] [Abstract][Full Text] [Related]
3. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Blasi G; Bertolino A; Brudaglio F; Sciota D; Altamura M; Antonucci N; Scarabino T; Weinberger DR; Nardini M Psychiatry Res; 2004 Jul; 131(2):95-105. PubMed ID: 15313516 [TBL] [Abstract][Full Text] [Related]
4. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. Russell A; Cortese B; Lorch E; Ivey J; Banerjee SP; Moore GJ; Rosenberg DR J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S31-8. PubMed ID: 12880498 [TBL] [Abstract][Full Text] [Related]
5. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373 [TBL] [Abstract][Full Text] [Related]
6. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy. Huang Y; Chen W; Li Y; Wu X; Shi X; Geng D Psychiatry Res; 2010 Apr; 182(1):48-52. PubMed ID: 20227856 [TBL] [Abstract][Full Text] [Related]
7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Wang Z; Zhao C; Yu L; Zhou W; Li K Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582 [TBL] [Abstract][Full Text] [Related]
8. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Senaratne R; Milne AM; MacQueen GM; Hall GB Psychiatry Res; 2009 Jun; 172(3):205-9. PubMed ID: 19386476 [TBL] [Abstract][Full Text] [Related]
9. (1)H magnetic resonance spectroscopy imaging of the hippocampus in patients with panic disorder. Trzesniak C; Uchida RR; Araújo D; Guimarães FS; Freitas-Ferrari MC; Filho AS; Santos AC; Busatto GF; Zuardi AW; Del-Ben CM; Graeff FG; Crippa JA Psychiatry Res; 2010 Jun; 182(3):261-5. PubMed ID: 20488674 [TBL] [Abstract][Full Text] [Related]
10. Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging. O'Brien FM; Page L; O'Gorman RL; Bolton P; Sharma A; Baird G; Daly E; Hallahan B; Conroy RM; Foy C; Curran S; Robertson D; Murphy KC; Murphy DG Psychiatry Res; 2010 Nov; 184(2):77-85. PubMed ID: 20952166 [TBL] [Abstract][Full Text] [Related]
11. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Yücel M; Harrison BJ; Wood SJ; Fornito A; Wellard RM; Pujol J; Clarke K; Phillips ML; Kyrios M; Velakoulis D; Pantelis C Arch Gen Psychiatry; 2007 Aug; 64(8):946-55. PubMed ID: 17679639 [TBL] [Abstract][Full Text] [Related]
12. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Atmaca M; Yildirim H; Ozdemir H; Ogur E; Tezcan E Psychol Med; 2007 Jan; 37(1):121-9. PubMed ID: 17094813 [TBL] [Abstract][Full Text] [Related]
13. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder. Scherk H; Backens M; Schneider-Axmann T; Kemmer C; Usher J; Reith W; Falkai P; Gruber O Acta Psychiatr Scand; 2008 Apr; 117(4):283-8. PubMed ID: 18205896 [TBL] [Abstract][Full Text] [Related]
14. Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications. Alkan A; Kutlu R; Kocak G; Sigirci A; Emul M; Dogan S; Aslan M; Sarac K; Yakinci C Eur J Radiol; 2004 Mar; 49(3):224-8. PubMed ID: 14962651 [TBL] [Abstract][Full Text] [Related]
15. Anterior to posterior hippocampal MRS metabolite difference is mainly a partial volume effect. Starck G; Vkhoff-Baaz B; Ljungberg M; Malmgren K; Forssell-Aronsson E; Jönsson L; Ekholm S Acta Radiol; 2010 Apr; 51(3):351-9. PubMed ID: 20201639 [TBL] [Abstract][Full Text] [Related]
16. [Proton magnetic resonance spectroscopic imaging of the hippocampus in schizophrenia patients before and after surgery]. Chang HM; Qi ST; Yang KJ; Wang KW; Guo ZW; Wang H Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):996-8. PubMed ID: 19460730 [TBL] [Abstract][Full Text] [Related]
17. A proton magnetic resonance spectroscopic study in juvenile absence epilepsy in early stages. Kabay SC; Gumustas OG; Karaman HO; Ozden H; Erdinc O Eur J Paediatr Neurol; 2010 May; 14(3):224-8. PubMed ID: 19616977 [TBL] [Abstract][Full Text] [Related]
18. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755 [TBL] [Abstract][Full Text] [Related]
19. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients. Fan Q; Tan L; You C; Wang J; Ross CA; Wang X; Zhang T; Li J; Chen K; Xiao Z Psychiatry Clin Neurosci; 2010 Oct; 64(5):483-90. PubMed ID: 20923427 [TBL] [Abstract][Full Text] [Related]
20. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression. Bédard MJ; Chantal S Psychiatry Res; 2011 Apr; 192(1):45-54. PubMed ID: 21377338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]